Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of AMRX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders161160−1
Shares101.6M99.9M−1.66M (−1.6%)
Value$683.6M$511.6M−$172.0M (−25.2%)

New holders (26)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to AMRX in Q2 2021
InstitutionSharesValue% of portfolio
Magnetar Financial LLC119,317$611.0K0.01%
Cetera Advisor Networks LLC90,055$461.0K0.01%
Truist Financial Corp75,385$386.0K0.00%
Squarepoint Ops LLC74,599$382.0K0.00%
Hennion & Walsh Asset Management, Inc.48,170$247.0K0.01%
ExodusPoint Capital Management, LP42,032$215.0K0.00%
PDT Partners, LLC36,020$184.0K0.01%
Susquehanna International Group, LLP30,846$158.0K0.00%
XTX Topco Ltd24,503$125.0K0.04%
Boothbay Fund Management, LLC24,239$124.0K0.01%
Gotham Asset Management, LLC20,929$107.0K0.00%
Ergoteles LLC19,300$99.0K0.00%
Bowling Portfolio Management LLC18,983$97.0K0.02%
Wedge Capital Management L L P18,602$95.0K0.00%
Ameriprise Financial Inc17,850$91.0K0.00%
Synovus Financial Corp15,222$78.0K0.00%
Rafferty Asset Management, LLC14,682$75.0K0.00%
Fox Run Management, L.L.C.14,184$73.0K0.07%
Man Group plc13,158$67.0K0.00%
Quantamental Technologies LLC12,207$63.0K0.06%
Highland Capital Management, LLC10,980$56.0K0.00%
Qtron Investments LLC10,861$56.0K0.01%
Strategic Blueprint, LLC3,000$15.0K0.00%
Advisory Services Network, LLC1,000$5.00K0.00%
Northwestern Mutual Wealth Management Co1$00.00%
O'Shaughnessy Asset Management, LLC61$00.00%

Sold out (27)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.